Compressible Mesh Occlusion Device for Aneurysm Flow Disruption

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current occlusion devices are inadequate for treating large and irregularly shaped aneurysms, particularly neurovascular aneurysms, as they fail to achieve sufficient flow disruption and compartmentalization, leading to incomplete occlusion and potential rupture risks.

Innovation Solution

A compressible mesh-based occlusion device with axial mesh carriages and discreet pinch points, designed to expand and fill the aneurysm sac, providing a 3-dimensional network for flow disruption and thrombus formation, suitable for larger and more complex aneurysm shapes.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Reliability

If traditional occlusion devices are used, then the treatment is simple and easy to deliver, but they fail to achieve sufficient flow disruption and compartmentalization for large and irregularly shaped aneurysms

Engineering Contradiction:
Improveocclusion effectivenessVSAvoiddevice structure
Core Design Contradiction:
ReliabilityVSDevice complexity

Solution Approach 1:

The occlusion device is divided into multiple compressible mesh carriages that can be independently deployed within the aneurysm sac. Each carriage creates localized flow disruption and compartmentalization, allowing the device to effectively occlude large and irregularly shaped aneurysms while maintaining a deliverable form through the catheter.

Inventive Principle:
Principle #1Segmentation

2Ease of operation

If the device is made compact for delivery, then it can be safely delivered through catheters, but it must expand to a larger size to achieve sufficient flow disruption and fill the aneurysm sac

Engineering Contradiction:
ImprovedeliverabilityVSAvoiddevice volume
Core Design Contradiction:
Ease of operationVSVolume of moving object

Solution Approach 1:

The mesh carriages are designed to be dynamically changeable in volume, transitioning from a compressed low-profile state during delivery through the catheter to an expanded state upon deployment within the aneurysm sac. This dynamic transformation allows the device to meet both deliverability requirements and therapeutic effectiveness requirements.

Inventive Principle:
Principle #15Dynamics

3Reliability

If the device expands to fill large aneurysms, then flow disruption and stasis are achieved, but the device must be large enough to accommodate various aneurysm sizes and shapes

Engineering Contradiction:
Improveflow disruptionVSAvoidaneurysm size accommodation
Core Design Contradiction:
ReliabilityVSAdaptability or versatility

Solution Approach 1:

The device consists of multiple modular mesh carriages that can be selectively deployed to match the size and shape of the aneurysm sac. This segmentation allows the device to adapt to varying aneurysm dimensions while collectively achieving sufficient flow disruption and stasis when fully expanded.

Inventive Principle:
Principle #1Segmentation

Solution Approach 2:

The compressible mesh carriage design provides universal applicability across different aneurysm sizes and shapes. The same basic carriage structure can be expanded to different volumes and configured to fit various geometries, making the device versatile for treating a wide range of aneurysm presentations.

Inventive Principle:
Principle #6Universality (Multi-functionality)

Data Source

PatentUS20250017593A1Occlusion Device
Publication Date: 2025.01.16 STRYKER IRELAND TECHNOLOGY LTD
  • US20250017593A1 patent drawing
  • US20250017593A1 patent drawing
  • US20250017593A1 patent drawing

AI summary

Provided herein is an occlusion device for implantation into a body lumen or aneurysm comprising, a continuous compressible mesh structure comprising axial mesh carriages configured end to end, wherein each end of each carriage is a pinch point in the continuous mesh structure. Also provided herein is a kit comprising the occlusion device disclosed herein and a means for delivery thereof. Methods of manufacture and use of the occlusion device are also disclosed.